Davenport A, Will E J, Davidson A M
Department of Renal Medicine, St. James's University Hospital, Leeds, UK.
Crit Care Med. 1993 Mar;21(3):328-38. doi: 10.1097/00003246-199303000-00007.
To determine whether continuous modes of renal replacement therapy result in improved cardiovascular stability compared with standard daily intermittent treatment in critically ill patients.
Prospective, randomized controlled trial.
Intensive care unit in a quaternary referral center for liver failure/transplantation.
Thirty-two consecutive, critically ill, mechanically ventilated patients with combined acute hepatic and renal failure.
Patients were randomized to treatment with either intermittent machine hemofiltration or continuous modes of renal replacement therapy; continuous arteriovenous hemofiltration (CAVH) or arteriovenous hemofiltration with dialysis (CAVHD), provided intracranial pressure was controlled.
Cardiac output, tissue oxygen delivery (DO2), and uptake were assessed during 32 treatments with intermittent machine hemofiltration (4 hrs) and during the first 5 hrs of 25 continuous treatments (CAVH and CAVHD). During the first hour of treatment, there was a reduction in cardiac index of 15 +/- 2% during intermittent machine hemofiltration compared with no significant change during the continuous modes of treatment (CAVH/CAVHD) (3 +/- 3%; p < .05). This reduction in cardiac output during intermittent machine hemofiltration was associated with a maximum reduction in mean arterial pressure from 82 +/- 2 to 66 +/- 2 mm Hg (p < .001), a reduction in pulmonary artery occlusion pressure of 27 +/- 4%, tissue DO2 of 15 +/- 3%, and tissue oxygen uptake of 12 +/- 5%, with no significant change in systemic vascular resistance and an increase in pulmonary vascular resistance of 50 +/- 12%. In addition, there was a maximum increase in intracranial pressure of 45 +/- 5% during the first hour of intermittent machine hemofiltration. There were no significant changes during the same time period during the continuous modes of renal replacement therapy.
In critically ill patients, in whom DO2 is impaired, the use of continuous forms of renal replacement therapy is preferred for its improved cardiovascular tolerance compared with daily intermittent machine treatments.
确定与标准的每日间歇性治疗相比,连续性肾脏替代治疗模式是否能改善重症患者的心血管稳定性。
前瞻性随机对照试验。
一家四级转诊中心的肝衰竭/移植重症监护病房。
32例连续的、重症的、接受机械通气的合并急性肝衰竭和肾衰竭的患者。
患者被随机分配接受间歇性机器血液滤过或连续性肾脏替代治疗;若颅内压得到控制,则采用连续性动静脉血液滤过(CAVH)或动静脉血液滤过透析(CAVHD)。
在32次间歇性机器血液滤过治疗(4小时)期间以及25次连续性治疗(CAVH和CAVHD)的前5小时内,评估心输出量、组织氧输送(DO2)和氧摄取。在治疗的第1小时,间歇性机器血液滤过期间心脏指数降低了15±2%,而连续性治疗模式(CAVH/CAVHD)期间无显著变化(3±3%;p<.05)。间歇性机器血液滤过期间心输出量的这种降低与平均动脉压从82±2降至66±2 mmHg的最大降幅相关(p<.001),肺动脉闭塞压降低27±4%,组织DO2降低15±3%,组织氧摄取降低12±5%,全身血管阻力无显著变化,肺血管阻力增加50±12%。此外,在间歇性机器血液滤过的第1小时内,颅内压最大升高45±5%。在连续性肾脏替代治疗模式的同一时间段内无显著变化。
在氧输送受损的重症患者中,与每日间歇性机器治疗相比,连续性肾脏替代治疗因其更好的心血管耐受性而更受青睐。